Dernières nouvelles pour NRX Pharmaceuticals (NASDAQ:NRXP) Stock

NRX Pharmaceuticals

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

NRX Pharmaceuticals Inc

Celsius Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) has outperformed the market over the past 10 years by 57.01% on an annualized basis producing an average annual return of 68.16%. Currently, Celsius Holdings has a market capitalization of $6.36 billion. 
Buying $1000 In CELH: If an investor had bought $1000 of CELH stock 10 years ago, it would be worth $180,826.48 today based on a price of $27.28 for CELH at the time of writing.
<h3>Celsius Holdings's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736806508_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

CELH

Here's How Much You Would Have Made Owning Celsius Holdings Stock In The Last 10 Years

"My first legal joint burned like hell. It was hot, the material was dried out, and it canoed," recalls Kyle Loucks, founder and CEO of <a href="https://www.benzinga.com/topic/rollpros">RollPros</a>, as he describes the experience that led to his work in the cannabis pre-roll space. For Loucks, that moment wasn't just a personal disappointment, it brought a major realization. What was supposed to be a magical milestone, celebrating legalization and quality craftsmanship, turned into an encounter with a product that fell far short of expectations. Instead of moving on, Loucks decided to do something about it.
<h3 class="wp-block-heading">The Problem With Pre-Rolls: A Connoisseur&#8217;s Perspective</h3>
Loucks&#8217; first pre-roll was meant to be a celebration, a symbol of how far the industry had come. Instead, it exposed a persistent problem in the market. "I saw a problem," he says. "This is not my level of joint." For someone who had spent more than 20 years perfecting the art of rolling by hand, encountering such a poorly made product sparked an idea. Retreating to his garage, Loucks began working on a solution that could deliver consistent, high-quality joints at scale.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152502/RollPros-Blackbird_1-1024x683.jpg" alt="RollPros Blackbird" class="wp-image-731271" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152502/RollPros-Blackbird_1-1024x683.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152502/RollPros-Blackbird_1-300x200.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152502/RollPros-Blackbird_1-768x512.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152502/RollPros-Blackbird_1-1536x1025.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152502/RollPros-Blackbird_1.jpg 1619w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
At the core of his solution is TruRoll technology, a proprietary system that flips the traditional cone-filling process on its side—literally. "We feed horizontally, so you can fill fresh, sticky weed with a big grind size. Then we roll it and tighten it as we go. It's just a better way to make a joint," Loucks explains.
The horizontal feeding approach addresses a common challenge with cones: their narrow aperture, which often leads to uneven packing and airflow issues. By rethinking the mechanics of rolling, Loucks developed a system that preserves the integrity of fresh flower while ensuring a consistent burn. His invention appeals not just to craft growers but also to larger operators looking for efficiency without sacrificing quality.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How To Roll The PERFECT JOINT: One Machine Produces 900 Pre-Rolls An Hour–They Are Better Than Cones" width="500" height="281" src="https://www.youtube.com/embed/-JhsMzXkjDw?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
<h3 class="wp-block-heading">Craft Meets Automation</h3>
RollPros&#8217; flagship product, the Blackbird Rolling System, is designed for cannabis enthusiasts who value both precision and consistency. It combines Loucks' hands-on experience with advanced automation to replicate the quality of hand-rolled joints on an industrial scale. "We've done over 80 million joints now and have about 160 machines out in the wild," Loucks shares, highlighting the growing demand for his technology.
The Blackbird's design focuses on preserving what makes a joint special. "I selfishly designed it for myself," Loucks says, emphasizing his personal standards as a cannabis connoisseur who values fresh flower and optimal burn quality. "I like a large grind size to keep all those flavonoids and terpenes on the plant," he adds. To complement this, RollPros sources high-quality paper from one of the oldest paper mills in France, ensuring an even, smooth burn.
Beyond quality, the Blackbird is also about flexibility. Operators can customize nearly every aspect of the rolling process, from density and draw resistance to the type of filter or paper used. "You can do big fatties, little pinners, ceramic tips, glass tips, wood tips—it's all customizable," Loucks explains. The machine's adaptability allows brands to tailor their products to meet the specific preferences of their customers, creating a unique identity in a competitive market.
<h3 class="wp-block-heading">Meeting The Needs Of Craft Growers And Beyond</h3>
For Loucks, the design of the Blackbird Rolling System was always rooted in serving the craft cannabis community, those who value quality and freshness over mass production. "It's really tailored for the craft grower," he explains. Inspired by the dedication of phenohunters and small-scale cultivators in places like the Emerald Triangle, Loucks wanted to create a tool that could seamlessly integrate into these operations while maintaining the standards of hand-rolled joints.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152511/Kyle-Loucks_Founder-and-CEO-RollPros-1024x683.jpg" alt="Kyle Loucks" class="wp-image-731274" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152511/Kyle-Loucks_Founder-and-CEO-RollPros-1024x683.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152511/Kyle-Loucks_Founder-and-CEO-RollPros-300x200.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152511/Kyle-Loucks_Founder-and-CEO-RollPros-768x512.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152511/Kyle-Loucks_Founder-and-CEO-RollPros-1536x1025.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152511/Kyle-Loucks_Founder-and-CEO-RollPros.jpg 1619w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
The Blackbird's compact size makes it an ideal fit for such setups. Measuring approximately four feet by two feet and standing about four feet tall, it's no larger than two college refrigerators placed side by side. "It's on casters, so you can roll it from room to room," Loucks adds.
However, the machine's utility doesn't stop at the craft level. The Blackbird has also gained traction among larger players in the cannabis industry, including multi-state operators (MSOs) looking for efficient and scalable solutions. "We've got all the way up to the big MSOs using our equipment," Loucks shares. "It's great to see the big guys starting to look at us and being like, ‘This is how you make a quality consumer experience.'"
<h3 class="wp-block-heading">The Investment And ROI Equation</h3>
Of course, innovation comes at a price. The Blackbird Rolling System is an investment, with a starting cost of approximately $250,000. For some operators, that might seem like a steep entry point, but Loucks points out that the machine's scalability and potential for high-volume output can make it a cost-effective choice in the long run. With the ability to produce roughly 900 joints per hour, the system can quickly pay for itself in the right hands.
Loucks recounts the story of a particularly resourceful customer who purchased a Blackbird and turned it into a mobile rolling service. "He had it in a trailer and would roll it onto farms to offer rolling as a service. Then he'd pack it back up and head to the next place," Loucks explains. This entrepreneurial approach not only provided immediate value to local growers but also allowed the customer to recoup his investment faster than expected.
For operators who may not have the upfront capital, RollPros offers leasing options to make the technology more accessible. This flexibility ensures that craft growers and boutique operations can still benefit from the Blackbird's capabilities without being priced out of the market.
<h3 class="wp-block-heading">Beyond Rolling: The Future Of Cannabis Innovation</h3>
While the Blackbird Rolling System has carved out a niche for itself in the cannabis pre-roll market, Loucks is already looking ahead to the next set of challenges facing the industry. "I think packaging is next," he says, pointing to sustainability as a critical area for improvement. The current options for pre-roll packaging often rely on single-use plastics or other environmentally unfriendly materials, a problem Loucks believes can be addressed with the same innovative mindset that brought TruRoll technology to life. "I want to find some more sustainable options for packaging, but I've got to do it with the same level of innovation that I did with the Blackbird."
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152507/Blackbird-Rolled-Joints_1-1024x683.jpg" alt="" class="wp-image-731273" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152507/Blackbird-Rolled-Joints_1-1024x683.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152507/Blackbird-Rolled-Joints_1-300x200.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152507/Blackbird-Rolled-Joints_1-768x512.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152507/Blackbird-Rolled-Joints_1-1536x1025.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152507/Blackbird-Rolled-Joints_1.jpg 1619w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Loucks' approach to problem-solving is rooted in collaboration. "I love to brainstorm," he shares. "Hit me up on LinkedIn, let's do a Zoom, I'll get the whiteboard out—tell me your problem." For Loucks, innovation doesn't happen in isolation. By inviting growers, operators and other industry professionals to share their pain points, he aims to create solutions that are not just technically sound but deeply aligned with the needs of the cannabis community.
<h3 class="wp-block-heading">Crafting A Ritual, One Joint At A Time</h3>
Despite the technological sophistication of the Blackbird, Loucks is quick to acknowledge the irreplaceable value of the human touch in cannabis culture. For many enthusiasts, rolling a joint is as much about the ritual as it is about the final product. Loucks, a self-described "ritual guy," understands this intimately. "Rolling a joint is like making espresso," he says. "It's about the smell, the feel, the whole experience."
This perspective is woven into the very fabric of RollPros. While the Blackbird enables consistent, high-quality production at scale, it doesn't seek to replace the craft of rolling by hand. Instead, it provides a tool for those who want to take their craft to the next level, blending tradition with innovation. "The people that are really successful with our machine are joint rollers and joint smokers," Loucks explains. "They know what a good joint feels like, and they can dial in the machine to hit all those same parameters."
<h3 class="wp-block-heading">A Growing Legacy</h3>
With more than 80 million joints produced and a growing roster of customers ranging from boutique craft growers to large-scale MSOs, RollPros is becoming a cornerstone of the cannabis pre-roll industry. Loucks credits much of this success to his ability to remain connected to the community he serves. Whether through brainstorming sessions, hands-on product development or simply sharing his passion for well-rolled joints, Loucks keeps his focus on the people who make the cannabis industry what it is.
As he reflects on his journey, Loucks remains energized by the challenges that lie ahead. "There are big problems all across the industry," he says. "And I'm here to help solve them."
Images courtesy of RollPros.

Cannabis

Exclusives

Interview

'This Is How You Make Quality Joints' - How One Machine Produces 900 Pre-Rolls An Hour And Why They're Better Than Cones

B2Gold Expects Total Gold Production To Be 970K - 1.075M Ounces; Reports Total Gold Production Of 186,001 Ounces In Q4

Guidance

Alamos Gold Says 3-Year Operating Guidance Outlines 24% Production Growth By 2027; Starts Construction On Lynn Lake

4 analysts have expressed a variety of opinions on Houlihan Lokey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLI#NYSE">HLI</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $180.5, a high estimate of $200.00, and a low estimate of $170.00. Witnessing a positive shift, the current average has risen by 7.6% from the previous average price target of $167.75.
<img src="https://www.benzinga.com/files/images/story/2025/1736805657_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Houlihan Lokey. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Aidan Hall</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$170.00</td>
<td>$172.00</td>
</tr>
<tr>
<td>Aidan Hall</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$172.00</td>
<td>$171.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Underweight</td>
<td>$180.00</td>
<td>$157.00</td>
</tr>
<tr>
<td>Manan Gosalia</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$200.00</td>
<td>$171.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Houlihan Lokey. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Houlihan Lokey compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into Houlihan Lokey's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HLI/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Houlihan Lokey analyst ratings.</a>
<h2>Unveiling the Story Behind Houlihan Lokey</h2>
Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&amp;A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.
<h3>Unraveling the Financial Story of Houlihan Lokey</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, Houlihan Lokey showcased positive performance, achieving a revenue growth rate of 23.12% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Houlihan Lokey's net margin is impressive, surpassing industry averages. With a net margin of 16.27%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Houlihan Lokey's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 4.94%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Houlihan Lokey's ROA excels beyond industry benchmarks, reaching 3.04%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.22.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Forecasting The Future: 4 Analyst Projections For Houlihan Lokey

During the last three months, 6 analysts shared their evaluations of ITT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITT#NYSE">ITT</a>), revealing diverse outlooks from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for ITT, revealing an average target of $173.17, a high estimate of $183.00, and a low estimate of $163.00. This current average has increased by 3.69% from the previous average price target of $167.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1736805647_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The perception of ITT by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vladimir Bystricky</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$181.00</td>
<td>$183.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$180.00</td>
<td>$171.00</td>
</tr>
<tr>
<td>Vladimir Bystricky</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$183.00</td>
<td>$176.00</td>
</tr>
<tr>
<td>Joseph Giordano</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$165.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Michael Halloran</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$163.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$167.00</td>
<td>$157.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to ITT. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of ITT compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for ITT's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into ITT's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ITT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on ITT analyst ratings.</a>
<h2>Unveiling the Story Behind ITT</h2>
ITT Inc is a diversified manufacturer of engineered critical components and customized technology solutions predominantly for the transportation, industrial and energy markets. The company's products include, brake pads, shock absorbers, pumps, valves, connectors, switches and others. Its operating segments are; Motion Technologies (MT), Industrial Process (IP), and Connect &amp; Control Technologies (CCT). The majority of the revenue is generated from the Motion Technologies segment which is a manufacturer of brake pads, shims, shock absorbers, energy absorption components and sealing technologies. Geographically, the company generates majority of the revenue from North America, and also has its presence in South America, Europe, Asia, Middle East and Africa.
<h3>Unraveling the Financial Story of ITT</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Over the 3 months period, ITT showcased positive performance, achieving a revenue growth rate of 7.68% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.
Net Margin: ITT's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 18.2% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): ITT's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 6.05%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): ITT's ROA excels beyond industry benchmarks, reaching 3.44%. This signifies efficient management of assets and strong financial health.
Debt Management: ITT's debt-to-equity ratio is below the industry average. With a ratio of 0.34, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Analyst Ratings: Simplified</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing ITT: Insights From 6 Financial Analysts

Across the recent three months, 14 analysts have shared their insights on Coterra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRA#NYSE">CTRA</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">9</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $33.79, a high estimate of $40.00, and a low estimate of $29.00. This upward trend is evident, with the current average reflecting a 7.03% increase from the previous average price target of $31.57.
<img src="https://www.benzinga.com/files/images/story/2025/1736805639_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
A comprehensive examination of how financial experts perceive Coterra Energy is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$37.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$33.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$40.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$32.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$35.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$35.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Devin McDermott</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$29.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$33.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$35.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$33.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Biju Perincheril</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$33.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$32.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Mike Scialla</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Overweight</td>
<td>$29.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$37.00</td>
<td>$36.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Coterra Energy. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Coterra Energy compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Coterra Energy's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Coterra Energy's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CTRA/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Coterra Energy analyst ratings.</a>
<h2>About Coterra Energy</h2>
Coterra Energy Inc is an independent oil and gas company engaged in the development, exploration, and production of oil, natural gas, and NGLs. The company's operations are primarily concentrated in three core operating areas; the Permian Basin in west Texas and southeast New Mexico, the Marcellus Shale in northeast Pennsylvania, and the Anadarko Basin in the Mid-Continent region in Oklahoma.
<h3>Breaking Down Coterra Energy's Financial Performance</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Coterra Energy's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 0.22%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.
Net Margin: Coterra Energy's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 18.47%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Coterra Energy's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 1.93%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Coterra Energy's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 1.23%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Coterra Energy's debt-to-equity ratio is below the industry average at 0.18, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTRA

Forecasting The Future: 14 Analyst Projections For Coterra Energy

Throughout the last three months, 5 analysts have evaluated APi Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APG#NYSE">APG</a>), offering a diverse set of opinions from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $43.4, a high estimate of $45.00, and a low estimate of $40.00. Surpassing the previous average price target of $42.80, the current average has increased by 1.4%.
<img src="https://www.benzinga.com/files/images/story/2025/1736805628_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The standing of APi Gr among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$43.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$45.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Andrew Wittmann</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$40.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$44.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$45.00</td>
<td>$45.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to APi Gr. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of APi Gr compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of APi Gr's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/APG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on APi Gr analyst ratings.</a>
<h2>All You Need to Know About APi Gr</h2>
APi Group Corp operates in two segments: Safety Services segment includes providing safety services in North America, Asia Pacific, and Europe, focusing on end-to-end integrated occupancy systems (fire protection solutions, Heating, Ventilation, and Air Conditioning and entry systems), including design, installation, inspection, and service of these integrated systems. These services are provided in commercial, education, healthcare, high tech, industrial, and special-hazard settings. Specialty Services segment includes providing a variety of infrastructure services and specialized industrial plant services, which include maintenance and repair of critical infrastructure such as underground electric, gas, water, sewer, and telecommunications infrastructure.
<h3>APi Gr's Financial Performance</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: APi Gr's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 2.35%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 3.4%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): APi Gr's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 2.14%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.77%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 1.06, APi Gr faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into APi Gr Stock: Analyst Perspectives (5 Ratings)

Across the recent three months, 11 analysts have shared their insights on Bicycle Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCYC#NASDAQ">BCYC</a>), expressing a variety of opinions spanning from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">7</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $35.18, along with a high estimate of $55.00 and a low estimate of $17.00. Experiencing a 12.27% decline, the current average is now lower than the previous average price target of $40.10. 
<img src="https://www.benzinga.com/files/images/story/2025/1736805620_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The analysis of recent analyst actions sheds light on the perception of Bicycle Therapeutics by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Swayampakula Ramakanth</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$33.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$32.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Reni Benjamin</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$26.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Swayampakula Ramakanth</td>
<td>HC Wainwright &amp; Co.</td>
<td>Lowers</td>
<td>Buy</td>
<td>$33.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Kalpit Patel</td>
<td>B. Riley Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$17.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Sudan Loganathan</td>
<td>Stephens &amp; Co.</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$25.00</td>
<td>-</td>
</tr>
<tr>
<td>Gregory Renza</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$35.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Swayampakula Ramakanth</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$55.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$38.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Swayampakula Ramakanth</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$55.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$38.00</td>
<td>$38.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Bicycle Therapeutics. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Bicycle Therapeutics compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Bicycle Therapeutics's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into Bicycle Therapeutics's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/BCYC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Bicycle Therapeutics analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>About Bicycle Therapeutics</h2>
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
<h3>Understanding the Numbers: Bicycle Therapeutics's Finances</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Challenges: Bicycle Therapeutics's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -50.0%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Bicycle Therapeutics's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -1898.43%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of -5.96%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Bicycle Therapeutics's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -4.95%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.01.
<h2>How Are Analyst Ratings Determined?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BCYC

Forecasting The Future: 11 Analyst Projections For Bicycle Therapeutics

During the last three months, 7 analysts shared their evaluations of A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>), revealing diverse outlooks from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $81.86, a high estimate of $91.00, and a low estimate of $73.00. Highlighting a 2.35% decrease, the current average has fallen from the previous average price target of $83.83. 
<img src="https://www.benzinga.com/files/images/story/2025/1736805611_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of A.O. Smith among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$73.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$90.00</td>
<td>$91.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$78.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$91.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Michael Halloran</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$81.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Damian Karas</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$80.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Matt Summerville</td>
<td>DA Davidson</td>
<td>Announces</td>
<td>Neutral</td>
<td>$80.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to A.O. Smith. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of A.O. Smith compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of A.O. Smith's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into A.O. Smith's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AOS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on A.O. Smith analyst ratings.</a>
<h2>All You Need to Know About A.O. Smith</h2>
A.O. Smith Corporation manufactures a broad lineup of water heaters, boilers, and water treatment products. The company has two reporting segments, North America (75% of sales) and rest of world (25% of sales). A.O. Smith is the leading manufacturer of water heaters in North America for both residential and commercial markets, with approximately 37% and 54% market share, respectively. Residential water heaters account for Most of North American sales and are distributed equally through wholesale and retail channels. Most of A.O. Smith's international revenue is from China, a market the company entered during the mid-1990s.
<h3>Financial Insights: A.O. Smith</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Decline in Revenue: Over the 3 months period, A.O. Smith faced challenges, resulting in a decline of approximately -3.72% in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: A.O. Smith's net margin excels beyond industry benchmarks, reaching 13.31%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): A.O. Smith's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 6.27%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): A.O. Smith's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.78% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: A.O. Smith's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.07.
<h2>The Basics of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What 7 Analyst Ratings Have To Say About A.O. Smith

Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) has outperformed the market over the past 10 years by 6.93% on an annualized basis producing an average annual return of 18.08%. Currently, Parker Hannifin has a market capitalization of $82.09 billion. 
Buying $1000 In PH: If an investor had bought $1000 of PH stock 10 years ago, it would be worth $5,267.42 today based on a price of $637.99 for PH at the time of writing.
<h3>Parker Hannifin's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736805608_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Parker Hannifin 10 Years Ago Would Be Worth This Much Today

CHCI

Comstock Holding Signs Three New Retail Leases At Loudoun Station

A federal judge in Florida has paved the way for the release of Special Counsel <a href="https://www.benzinga.com/topic/jack-smith">Jack Smith's</a> final report on his inquiry into President-elect Donald Trump and charges alleging election interference. The report could be made public as early as Tuesday.
In the Monday announcement, <a href="https://www.washingtonpost.com/national-security/2025/01/13/jack-smith-report-trump-cannon-garland-jan-6/">reported</a> by the Washington Post, U.S. District Judge Aileen Cannon authorized the Justice Department to release the first volume of Smith&#8217;s report. This decision follows her earlier temporary block on the report&#8217;s release, pending an appeals court ruling.
Cannon, who was appointed by Trump, denied motions from Trump&#8217;s former co-defendants, Walt Nauta and Carlos De Oliveira, who sought to prevent the report&#8217;s publication.
The Justice Department (DOJ) plans to release the first volume, focusing on the election interference investigation. Cannon said the government could not — to avoid impacting ongoing cases — release a separate volume that details Smith's investigation into Trump's obstruction over the mishandling of classified documents, which he <a href="https://www.benzinga.com/news/22/08/28484168/top-secret-classified-documents-recovered-from-trumps-mar-a-lago-home-heres-what-you-need-to-know">took to his Florida Mar-a-Lago residence</a> and refused to hand over to the FBI.
Smith, who led the investigations, resigned from the DOJ on Jan. 10 after submitting his final report. The DOJ&#8217;s decision to release the report comes after dropping federal cases against Trump, citing policy against prosecuting a sitting president.
Meanwhile, Trump&#8217;s legal team has argued that the special counsel&#8217;s appointment was unlawful and that releasing the report could harm his transition into the White House. They may appeal to the U.S. Supreme Court to block the report&#8217;s release.
In that Trump takes office next Monday, Jan. 20, time is running out for Garland to release any part of the report.
The DOJ has been fighting in court about whether it's permitted to publicly release Smith's final report about his cases against Trump. Such a report is an obligatory part of the special counsel&#8217;s work and could be the last opportunity for prosecutors to explain their decisions after they dropped the federal cases against Trump following his election victory in November.&nbsp;
The Washington Post noted that over the weekend, Trump's co-defendants had asked Cannon to extend that embargo and keep Smith's report permanently under wraps.
Justice Department lawyers appealed to the 11th Circuit seeking the green light for an earlier release, maintaining that nothing in the report would interfere with Nauta and De Oliveira's rights.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/42152895/trump-plans-doj-overhaul-including-firing-of-jack-smiths-team">Trump Plans DOJ Overhaul Including Firing of Jack Smith&#8217;s Team</a></li>
</ul>
Photo: Shutterstock

Government

Politics

Legal

Trump-Appointed Federal Judge Greenlights Jan 6. Report: Could Be Made Public As Early As Tuesday

The Duchess of Sussex Meghan Markle and streaming partner Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) are delaying the launch of a new cooking reality show from January to March due to <a href="https://www.benzinga.com/general/entertainment/25/01/42888380/los-angeles-fires-shut-down-production-of-tv-shows-fallout-abbott-elementary-hacks-film-premieres-canceled-critics-choice-awards-delayed">the California wildfires.</a>
What Happened: The new series titled "With Love, Meghan" featuring the Duchess of Sussex cooking, gardening and decorating is one of<a href="https://www.benzinga.com/general/entertainment/24/04/38237862/meghan-markle-prince-harry-line-up-new-projects-with-netflix-heres-what-the-shows-are-about"> several projects between</a> Netflix and the actress.
Originally set for a January 15 premiere, viewers will now have to wait until March 4 to watch the reality series.
"I'm thankful to my partners at Netflix for supporting me in delaying the launch, as we focus on the needs of those impacted by the wildfires in my home state of California," Markle <a href="https://www.netflix.com/tudum/articles/with-love-meghan-season-1-release-date-news?utm_source=mediacenter">said</a>.
The eight-episode series features Meghan with friends and other special guests including Roy Choi, Mindy Kaling and Alice Waters. Markle's husband Prince Harry is also reported to have been featured in at least one of the episodes.
"Meghan shares personal tips and tricks, embracing playfulness over perfection, and highlights how easy it can be to create beauty, even in the unexpected. She and her guests roll up their sleeves in the kitchen, the garden, and beyond, and invite you to do the same," Netflix said of the series.
The series was shot in Montecito, California.
Read Also: <a href="https://www.benzinga.com/news/24/09/40672479/meghan-markle-says-she-invested-in-a-luxury-brand-after-googling-about-it-calls-her-approach-dolphin">Meghan Markle Says She Invested In A Luxury Brand After &#8216;Googling&#8217; About It, Calls Her Approach &#8216;Dolphin Tank&#8217; Instead Of &#8216;Shark Tank:&#8217; &#8216;These Are Friendly Waters&#8217;</a>
Why It's Important: The delay of the Markle reality show on Netflix comes as the wildfires have impacted the entertainment industry and left several celebrities without their Los Angeles area homes.
Several movies that premiered in theaters or will soon premiere were forced to cancel their Los Angeles premieres last week due to the wildfires.
Television shows also saw the shutdown of production studios, which could delay the timing of episode releases in the future.
The timing of television shows on network and streaming and movies could see delays in their releases and Los Angeles premiere events.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/25/01/42956034/netflix-stock-has-long-term-runway-for-dominance-in-streaming-analyst-highlights-4-key-catalysts">Netflix Stock Has &#8216;Long Term Runway For Dominance In Streaming&#8217;: Analyst Highlights 4 Key Catalysts</a></li>
</ul>
Photo courtesy of Netflix

Entertainment

NFLX

Meghan Markle, Netflix Delay Launch Of Cooking Reality Show After California Fires: 'Focus on The Needs Of Those Impacted'

Cryptocurrency markets reversed a weak start to the week on news that Donald Trump reportedly plans signing sseveral crypto-related executive orders on his <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42962279/trump-could-sign-crypto-related-executive-orders-on-day-1-report">first day in office</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td> $94,357</td>
<td>-0.1%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td> $3,117</td>
<td>-4.5%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td> $181.90</td>
<td>-3.3%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td> $2.54</td>
<td>+0.9%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td> $0.3358</td>
<td>-0.0%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td> $0.00002108</td>
<td>-2.2%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows large transaction volume increasing by 9.2% and daily active addresses up by 6.4%. Transactions greater than $100,000 are down from 7,112 to 6,648 in a single day. Exchanges netflows are down by 147.8%.</li>
<li>Coinglass data reports 273,610 traders were liquidated in the past 24 hours for $764.74 million. Long liquidations of $587.9 million came in at a three-week high.</li>
<li>Crypto chart analyst Ali Martinez <a href="https://x.com/ali_charts/status/1878617460661989825">noted</a> Bitcoin network activity having fallen to its lowest level since November 2024, with just 667,100 active addresses.</li>
<li>In another <a href="https://x.com/ali_charts/status/1878695475026780311">tweet</a>, he sees number of large transactions on the Bitcoin network has decreased by 51.64% over the past month, dropping from 33,450 to 16,180.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42956569/tether-to-relocate-headquarters-to-el-salvador">Tether To Relocate Headquarters To El Salvador</a></li>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/42950202/bitcoins-2024-revolution-etps-double-crypto-market-cap-big-winners-emerge">Bitcoin&#8217;s 2024 Revolution: ETPs Double Crypto Market Cap, Big Winners Emerge</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42940832/jamie-dimon-says-hes-not-against-blockchains-but-trades-guns-on-bitcoin-again-it-has-no-intrinsic-value-i-just-dont-feel-great-about">Jamie Dimon Says He&#8217;s Not Against Blockchains But Trades Guns On Bitcoin Again—It Has No Intrinsic Value: &#8216;I Just Don&#8217;t Feel Great About&#8230;&#8217;</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42944474/donald-trump-jr-joins-kalshi-prediction-market-as-strategic-advisor">Donald Trump Jr. Joins Kalshi Prediction Market As Strategic Advisor</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42946219/microstrategy-acquires-2530-bitcoin-for-243m-reaching-450000-btc-in-total-holdings">MicroStrategy Acquires 2,530 Bitcoin For $243M, Reaching 450,000 BTC In Total Holdings</a></li>
</ul>
Top Losers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>DeXe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">DEXE</a>)</td>
<td>&nbsp;$13.57</td>
<td>-16%</td>
</tr>
<tr>
<td>Ethena (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">ENA</a>)</td>
<td>&nbsp;$0.7651</td>
<td>-14.5%</td>
</tr>
<tr>
<td>Bitcoin SV (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">BSV</a>)</td>
<td>&nbsp;$51.36</td>
<td>-12.1%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: With Bitcoin prices dropping, crypto trader Jelle <a href="https://x.com/CryptoJelleNL/status/1878755619999740386">suggested</a> it could be a "Red Monday, green week."
In another tweet, he highlighted that Bitcoin's daily candle is shaping up well, noting that a close above $92,500 would increase the likelihood of marking a bottom.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Daily candle shaping up nicely with four hours to go. Close above $92,500 and odds are high that was the bottom. Let&#39;s see! <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> <a href="https://t.co/GtgbaUKMaC">pic.twitter.com/GtgbaUKMaC</a>
&mdash; Jelle (@CryptoJelleNL) <a href="https://twitter.com/CryptoJelleNL/status/1878891414194692598?ref_src=twsrc%5Etfw">January 13, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto trader Rekt Capital <a href="https://x.com/rektcapital/status/1878787059600818514">emphasized</a> the importance of a daily close above ~$91,000 to sustain the $91,000-$101,000 range and preserve the early-stage higher low on the RSI.
Meanwhile, crypto trader Seth views $170,000 as a conservative Bitcoin top target within a broader $150,000-$300,000 range. 
This aligns with historical bull cycles where Bitcoin often overshoots expectations, depending on liquidity influx. 
Seth added that if $170,000 is treated as a baseline, there's potential for further upside driven by macro conditions, institutional adoption, or retail FOMO. 
Key <a href="https://x.com/seth_fin/status/1878876134777262174">factors</a> like halving effects and global liquidity will play a major role in determining how realistic this target is.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42957400/bitcoins-big-macro-data-week-heres-what-to-watch">Bitcoin&#8217;s Big Macro Data Week: Here&#8217;s What To Watch</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BSV

$BTC

$DEXE

$DOGE

$ENA

$ETH

$SHIB

$SOL

$XRP

Bitcoin, Ethereum, XRP, Dogecoin Reverse 'Red Monday' On Bullish Trump News

Management

RPM Appoints Three Individuals, Craig Morford, Christopher Mapes And Julie Beck, To Its Board

KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) reported financial results for the fourth quarter after the market close on Monday. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/25/01/b42961336/kb-home-reports-2024-fourth-quarter-and-full-year-results">of the report</a>. 
Q4 Earnings: KB Home reported fourth-quarter revenue of $2 billion, beating analyst&nbsp;<a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">estimates</a>&nbsp;of $1.99 billion. The U.S. homebuilder&nbsp;reported fourth-quarter earnings of $2.52 per share, beating analyst estimates of $2.39 per share, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Total revenue was up 19% year-over-year. KB Home delivered 3,978 homes in the quarter, up 17% year-over-year. Average selling price was&nbsp;$501,000, up 3%, and net orders climbed 41% year-over-year to 2,688.
&#8220;Our higher revenues reflected an increase in deliveries, which were driven by faster build times. Net orders rose roughly&nbsp;40%&nbsp;year over year, as buyers continued to demonstrate a desire for homeownership and housing market conditions improved relative to last year, despite ongoing mortgage interest rate headwinds,&#8221; said Jeffrey Mezger, chairman and CEO of KB Home.
&#8220;In 2025, we will remain focused on expanding our scale, profitability and returns. We believe we are poised for growth having invested over&nbsp;$2.8 billion&nbsp;in land acquisition and development in 2024, and we plan to increase our investment again in 2025.&#8221;
KB Home said it repurchased $100 million worth of its common stock during the quarter. The company had $700 million remaining under its buyback program as of Nov. 30.
Guidance: KB Home expects full-year 2025 housing revenue to be in the range of $7 billion to $7.5 billion. The company anticipates 2025 average selling prices of $488,000 to $498,000. 
KB Home noted that it will provide guidance for the first quarter on its conference call, which is scheduled for 5 p.m. ET.
KBH Price Action: <a href="https://www.benzinga.com/quote/KBH" target="_blank" rel="noreferrer noopener">KB Home shares</a> were up 8% at $69.24 at the time of publication Monday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/01/42959459/whats-going-on-with-united-states-steel-shares-monday">What&#8217;s Going On With United States Steel Shares Monday?</a></li>
</ul>
Photo: Shutterstock.

Earnings

Movers

KB Home Q4 Earnings: Revenue Beat, EPS Beat, Home Deliveries Up 17%, Net Orders Soar And More

PTLO

Portillo's Expects 2025 Revenue Growth Of 11%-12%, Same Restaurant Sales To Be Flat To Up 2%

Ares Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARES#NYSE">ARES</a>) has outperformed the market over the past 5 years by 24.46% on an annualized basis producing an average annual return of 36.32%. Currently, Ares Management has a market capitalization of $35.43 billion. 
Buying $1000 In ARES: If an investor had bought $1000 of ARES stock 5 years ago, it would be worth $4,764.87 today based on a price of $175.49 for ARES at the time of writing.
<h3>Ares Management's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736804708_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARES

Here's How Much $1000 Invested In Ares Management 5 Years Ago Would Be Worth Today

The incoming Trump administration is set to dramatically alter the landscape of cryptocurrency regulation, with prominent tech and crypto leaders taking influential positions <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42701446/crypto-industry-anticipates-policy-overhaul-under-trump-administration">in shaping policy</a>. 
What Happened: According <a href="https://www.washingtonpost.com/politics/2025/01/13/andreessen-tech-industry-trump-administration-doge/">to</a> The Washington Post, venture capitalist Marc Andreessen has emerged as a key figure in the transition, leveraging his Silicon Valley expertise to recruit candidates for crucial positions across Washington.
Andreessen, co-founder of Andreessen Horowitz, has been actively involved in interviewing and recommending candidates for various roles, including those related to <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41770352/bitcoins-future-under-president-elect-donald-trump-a-look-at-his-crypto-policies">cryptocurrency policy</a>. 
His influence stems from a meeting with Trump last summer, where the President-elect&#8217;s message about beating China in the tech race resonated with the venture capitalist.
The Trump transition team has made <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42480856/donald-trump-pledges-to-do-something-great-with-crypto-heres-what-hes-done-so-far">crypto regulation</a> a priority, with plans to address issues like &#8220;<a href="https://www.benzinga.com/markets/cryptocurrency/23/07/33437300/trump-supporter-nigel-farage-aims-to-tackle-de-banking-theres-solution-at-the-ready-bitcoi">de-banking</a>&#8221; and controversial accounting policies on day one of the presidency. 
David Sacks, appointed as Trump&#8217;s AI and <a href="https://www.benzinga.com/24/12/42356067/venture-capitalist-david-sacks-appointed-as-white-house-ai-crypto-czar-by-trump">crypto czar</a>, is working closely with industry leaders to finalize a legislative strategy.
&#8220;There has been an effort in the Washington bureaucratic swamp to stifle innovation with more regulation and higher taxes,&#8221; said Brian Hughes, a spokesperson for the Trump-Vance transition. 
He added that the administration aims to &#8220;develop a legal framework so the crypto industry can thrive in the United States.&#8221;
According to the report, Trump is expected to issue executive orders on day one of his presidency, possibly addressing de-banking and <a href="https://www.benzinga.com/24/12/42502213/new-crypto-accounting-standards-from-todaywill-it-boost-bitcoins-corporate-adoption">fair value accounting</a>, which requires banks holding cryptocurrencies to count them as liabilities on their balance sheet.
Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42956569/tether-to-relocate-headquarters-to-el-salvador">Tether To Relocate Headquarters To El Salvador</a>
Why It Matters: The tech industry&#8217;s increased involvement in the transition reflects frustrations with the Biden administration&#8217;s approach to regulating cryptocurrencies.
Andreessen described Trump&#8217;s victory as &#8220;a boot off the throat&#8221; during a November podcast, indicating the industry&#8217;s hope for a more favorable regulatory environment.
This shift aligns with recent expert opinions expressed at the <a href="https://www.benzinga.com/news/events/24/12/42441532/what-does-fair-value-accounting-mean-for-bitcoin-in-corporate-strategy">Benzinga Future of Digital Assets conference</a>, where panelists emphasized the need for regulatory clarity to unlock institutional growth in the digital asset market. 
Adam Guren of Hunting Hill Global Capital noted that regulatory uncertainty has been a major impediment to institutional adoption.
Ben Horowitz and Marc Andreessen have <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41976407/ben-horowitz-the-biden-regulators-lied-about-crypto">criticized the Biden administration&#8217;s crypto regulations</a>, accusing regulators of undermining legitimate businesses while allowing questionable projects to thrive. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42944474/donald-trump-jr-joins-kalshi-prediction-market-as-strategic-advisor">Donald Trump Jr. Joins Kalshi Prediction Market As Strategic Advisor</a></li>
</ul>
Image: Shutterstock

Trump Could Sign Crypto-Related Executive Orders On Day 1: Report

ALT5 Sigma

Anebulo Pharmaceuticals, Inc. - Common Stock

Anebulo Pharmaceuticals

AN2 Therapeutics

Assertio Holdings

CalciMedica

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Clearside Biomedical, Inc. - Common Stock

Clearside Biomedical

Context Therapeutics

Cumberland Pharmaceuticals Inc. - Common Stock

Cumberland

Journey Medical Corporation - Common Stock

Journey Medical

Grace Therapeutics

Ikena Oncology

Opus Genetics

Iterum Therapeutics

Lexaria Bioscience

Nutriband

OptiNose

Oramed Pharmaceuticals Inc. - Common Stock

Oramed Pharmaceuticals

Rani Therapeutics Holdings, Inc. - Class A Common Stock

Rani Therapeutics Hldgs

Regencell Bioscience Holdings Limited - Ordinary Shares

Regencell Bioscience

Reviva Pharmaceuticals Holdings, Inc. - Common Stock

Reviva Pharmaceuticals

Scilex Holding

SCYNEXIS

Verrica Pharmaceuticals Inc. - Common Stock

Comments

NRX Pharmaceuticals

Actualités

Dernières nouvelles pour NRX Pharmaceuticals (NASDAQ:NRXP) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL